Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Publisher:
New England Journal of Medicine
Date published:
2013
Record type:
Journal Title:
The New England Journal of Medicine
Source:
The New England Journal of Medicine, Vol. 369, No. 3, July 18, 2013, pp. 213-223
Subject:
Abstract:
In a study involving men with castration-resistant prostate cancer and bone metastases, the alpha emitter radium-223 significantly prolonged survival, as compared with placebo, and was associated with fewer adverse events.
Language:
Catagory URL:
CITATION: Parker C. [etal]. Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer . : New England Journal of Medicine , 2013. The New England Journal of Medicine, Vol. 369, No. 3, July 18, 2013, pp. 213-223 - Available at: https://library.au.int/alpha-emitter-radium-223-and-survival-metastatic-prostate-cancer-4